Director TitleAgeSince
Chairman - -
Chairman - 28/06/2012
Director/Board Member - 24/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 2.32Cr
+0.21%-7.67%+61.07%+71.32% 6.89TCr
+1.66%-9.54%+10.39%+60.04% 5.19TCr
+3.14%+4.61%+15.36%+44.42% 4.87TCr
+3.45%+4.70%+33.44%+36.21% 4.31TCr
-2.20%+0.61%+281.88%+454.69% 4.15TCr
+6.43%+6.84%+18.32%+115.06% 4TCr
+1.28%-0.76%+12.67%+45.10% 3.06TCr
-2.21%-14.22%+40.33%-0.94% 2.6TCr
+1.74%-2.02%-13.55%-6.98% 2.23TCr
Average +1.46%-3.90%+51.10%+90.99% 4.14TCr
Weighted average by Cap. +1.56%-3.49%+54.95%+97.63%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock